Kenneth L. Davis, M.D., is president and CEO of the Mount Sinai Health System in New York City, one of the nation's largest integrated health systems. As a neurobiologist, Davis's pioneering research led the FDA to approve four of the first five drugs for the treatment of Alzheimer's disease. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. The author or co-author of more than 575 scientific articles, Davis has been recognized as one of the most highly cited researchers in the field of brain diseases. He has won awards from several organizations, most notably the Alzheimer's Association, the Society of Biological Psychiatry, and the American Psychiatric Association. He was also awarded the George H. W. Bush Lifetime of Leadership Award from Yale University. In 2014 he was named a trustee of the Aspen Institute.